酰胺质子转移加权成像联合脂肪分数成像诊断三阴性乳腺癌
本回顾性研究纳入107例术前接受APTw和mDixon-Quant MRI的乳腺癌患者,分为三阴性乳腺癌组(24例)和非三阴性乳腺癌组(83例)。三阴性乳腺癌组Ki-67指数、APTw和T2*值显著更高,FF值更低;APTw联合FF诊断的AUC为0.885,加Ki-67后AUC升至0.911但差异无统计学意义。作者认为APTw联合mDixon-Quant可为术前诊断三阴性乳腺癌提供有价值的无创影像证据。
要点
- 三阴性乳腺癌组APTw和T2*值显著高于非三阴性乳腺癌组,FF值显著更低。
- APTw联合FF诊断三阴性乳腺癌的AUC为0.885,联合Ki-67后AUC为0.911但差异无统计学意义。
- APTw联合mDixon-Quant或可为术前无创识别三阴性乳腺癌提供影像依据。
核心结论
- APTw联合mDixon-Quant为术前诊断三阴性乳腺癌提供有价值的无创影像证据,有助于指导临床治疗策略和预后评估。
研究设计与样本
- 回顾性研究,纳入107例术前接受APTw和mDixon-Quant MRI的乳腺癌患者,依据免疫组化分为三阴性乳腺癌组(n=24)和非三阴性乳腺癌组(n=83),由两名放射科医师独立测量APTw、FF和T2*值,以ICC评估观察者间一致性,采用ROC分析和DeLong检验比较诊断效能。
关键影像表现/征象
- 三阴性乳腺癌组Ki-67指数、APTw和T2*值显著高于非三阴性乳腺癌组(均p<0.05)。
- 三阴性乳腺癌组FF值显著低于非三阴性乳腺癌组(p<0.05)。
诊断标准与关键数值
- APTw联合FF诊断三阴性乳腺癌的AUC为0.885。
- APTw联合FF再加Ki-67指数诊断三阴性乳腺癌的AUC为0.911,与前者差异无统计学意义(p>0.05)。
临床应用与阅片要点
- 作者认为APTw联合mDixon-Quant可为术前三阴性乳腺癌诊断提供有价值的无创影像证据,并指导临床治疗策略和预后评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the diagnostic value of amide proton transfer-weighted imaging (APTw) combined with modified Dixon fat quantitation technique (mDixon-Quant) for differentiating triple-negative breast cancer (TNBC) from non-TNBC.
MATERIALS AND METHODS: This retrospective study included 107 breast cancer patients who underwent preoperative MRI with APTw and mDixon-Quant. Based on immunohistochemistry, patients were classified into TNBC (n=24) and non-TNBC (n=83) groups. Two radiologists independently measured APTw, fat fraction (FF), and T2* values. Interobserver consistency was assessed using the intraclass correlation coefficient (ICC). Continuous and categorical variables were compared using the Mann-Whitney U and χ² tests, respectively. Diagnostic performance was evaluated and compared using receiver operating characteristic (ROC) analysis, with the DeLong test for AUC comparisons.
RESULTS: The TNBC group showed significantly higher Ki-67 index, APTw, and T2* values, but lower FF values than the non-TNBC group (all p<0.05). The combined use of APTw and FF values demonstrated favorable diagnostic efficacy, with an AUC of 0.885. Adding Ki-67 index increased the AUC to 0.911, but the difference was not significant (p>0.05).
CONCLUSION: APTw combined with mDixon-Quant provides valuable non-invasive imaging evidence for preoperative TNBC diagnosis, guiding clinical treatment strategies and prognostic assessment.
引用
- Yin X, Wang S, Guo Z, et al. Amide Proton Transfer-Weighted Imaging Combined with Fat Fraction Imaging for Diagnosis of Triple-Negative Breast Cancer. Acad Radiol. 2026. PMID: 41781261. doi:10.1016/j.acra.2026.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。